Earnings Outlook For Regeneron Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NASDAQ:REGN) is scheduled to release its quarterly earnings report on 2024-02-02, with analysts expecting an EPS of $10.77. Historical data shows mixed reactions to past earnings, with slight share price movements post-announcement. Shares are currently trading at $942.78, reflecting a 20.6% increase over the last 52 weeks. Investors are looking for positive guidance for the next quarter.
February 01, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Regeneron Pharmaceuticals is expected to announce an EPS of $10.77 for the latest quarter. Historical performance shows minor price changes post-earnings, with a 20.6% increase in share price over the last year.
Given the positive long-term share performance and anticipation of beating the EPS estimate, there's a likely short-term positive impact. However, the historical slight price drops post-earnings suggest cautious optimism.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100